Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Clinical trial NCT03786094 · TERMINATED
Trial details
- NCT number
- NCT03786094
- Sponsor
- Spexis AG
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2021-10-19
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.